Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.69 EUR | +0.89% | +13.80% | +32.94% |
Apr. 17 | OSE: licensing agreement with AbbVie enters into force | CF |
Apr. 17 | OSE Immunotherapeutics Finalizes Drug License, Collaboration Deal With AbbVie | MT |
- Stock Market
- Equities
- OSE Stock
- News OSE Immunotherapeutics